ANDA 70167, held by Duramed Pharmaceuticals (Barr). Tolazamide.
As of Nov 21, 2026, ANDA 70167 (Tolazamide), held by Duramed Pharmaceuticals (Barr), was first approved by FDA on Jan 10, 1986, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 10, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tolazamide500MG · tablet;oral | Tolazamide | Discontinued |
| Feb 22, 1989 | Supplement 7Labeling | Approved | None posted |
| May 9, 1988 | Supplement 5Labeling | Approved | None posted |
| Jan 10, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters